Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M51.1Revenue $M15.5Net Margin (%)-143.6Altman Z-Score-14.0
Enterprise Value $M26.3EPS $-0.4Operating Margin %-124.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score1.3Pre-tax Margin (%)-143.6Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %--Quick Ratio4.2Cash flow > EarningsN
Price/Sales3.15-y EBITDA Growth Rate %--Current Ratio4.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-106.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M58.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AVEO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AVEOSeth Klarman 2014-12-31 Sold Out -0.07%$0.65 - $1.17
($0.91)
$ 0.88-3%Sold Out0
AVEOGeorge Soros 2014-09-30 Sold Out $1.09 - $1.79
($1.26)
$ 0.88-30%Sold Out0
AVEOGeorge Soros 2014-06-30 Buy $1.02 - $1.72
($1.29)
$ 0.88-32%New holding49,076
AVEOSeth Klarman 2013-06-30 Reduce-0.26%$2.34 - $8.27
($4.27)
$ 0.88-79%Reduce -21.90%3,829,350
AVEOGeorge Soros 2011-12-31 Sold Out -0.0031%$14.53 - $17.35
($8.42)
$ 0.88-90%Sold Out0
AVEOSeth Klarman 2011-09-30 Add0.29%$15.12 - $20.77
($17.66)
$ 0.88-95%Add 12.79%5,000,000
AVEOGeorge Soros 2011-09-30 Reduce-0.04%$15.12 - $20.77
($17.66)
$ 0.88-95%Reduce -92.80%11,600
AVEOSeth Klarman 2011-06-30 Add0.78%$13.06 - $20.66
($16.79)
$ 0.88-95%Add 25.76%4,433,010
AVEOGeorge Soros 2011-06-30 Buy 0.05%$13.06 - $20.66
($16.79)
$ 0.88-95%New holding161,000
AVEOSeth Klarman 2011-03-31 Add1.15%$13.15 - $15.02
($14.21)
$ 0.88-94%Add 76.25%3,525,000
AVEOSeth Klarman 2010-12-31 Buy 1.68%$13.84 - $17.41
($15.14)
$ 0.88-94%New holding2,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AVEO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AVEO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dallas Matthew DVP, Finance 2015-01-16Sell3,075$0.827.32view
Gyuris JenoSVP, Chief Scientific Officer 2015-01-07Sell4,484$0.810view
Vittiglio JosephSVP, General Counsel 2015-01-07Sell4,484$0.810view
Dallas Matthew DVP, Finance 2015-01-07Sell519$0.810view
BAILEY MICHAEL PPresident & CEO 2015-01-07Sell4,484$0.810view
Dallas Matthew DVP, Finance 2014-07-01Sell0$010view
BAILEY MICHAEL PChief Business Officer 2014-01-30Sell5,430$1.64-46.34view
Slichenmyer WilliamChief Medical Officer 2014-01-30Sell5,430$1.64-46.34view
Gyuris JenoSVP, Chief Scientific Officer 2014-01-30Sell5,430$1.64-46.34view
Vittiglio JosephSVP, General Counsel 2014-01-30Sell5,430$1.64-46.34view

Quarterly/Annual Reports about AVEO:

    News about AVEO:

    Articles On GuruFocus.com
    Wild Card Wonders, Shopping for 52-Week Lows Sep 28 2013 
    Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low Sep 03 2013 
    Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA Dec 16 2012 
    Seth Klarman’s Baupost Group Buys Microsoft Corp., BP, Allied Nevada Gold, Sells Audiovox Corp. Aug 12 2011 
    Seth Klarman’s Baupost Group Q1 Portfolio Update; Buys ANV, SCMR, PDLI, AVEO May 14 2011 
    AVEO Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 11 2011 
    Two Picks from Seth Klarman: PDLI, AVEO Feb 22 2011 
    Hedge Fund Baupost Group buys PDLI, AVEO, ALR, Sells LSTZA, UFS, SLRC, EXXI Feb 11 2011 

    More From Other Websites
    AVEO to Present at the 18th Annual BIO CEO & Investor Conference Feb 02 2016
    The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion... Jan 12 2016
    AVEO to Present at Biotech Showcase 2016 Jan 06 2016
    AVEO to Present at Biotech Showcase 2016 Jan 06 2016
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 05 2016
    AVEO Licenses Tivozanib European Rights to EUSA Pharma Dec 22 2015
    Traders Look to Upside - New Reports on Pep Boys, Changyou.Com, Rewalk Robotics and Aveo... Dec 22 2015
    Why Are These Stocks Posting Gains on Monday? Dec 21 2015
    EXCLUSIVE: AVEO CEO Explains How New Partnership Will Address $500 Million Opportunity Overseas Dec 21 2015
    How AVEO Is Winning on Its Newest Licensing Agreement Dec 21 2015
    4 Stocks Trading With Heavy Volume Today Dec 21 2015
    AVEO Pharmaceuticals (AVEO) Stock Pops on European Licensing Agreement Dec 21 2015
    AVEO Oncology and EUSA Pharma Announce Exclusive Licensing Agreement for Tivozanib In Renal Cancer -... Dec 21 2015
    AVEO PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Dec 21 2015
    AVEO and EUSA Pharma Announce Exclusive Licensing Agreement for Tivozanib in Europe Dec 21 2015
    AVEO and EUSA Pharma Announce Exclusive Licensing Agreement for Tivozanib in Europe Dec 21 2015
    AVEO and EUSA Pharma Announce Exclusive Licensing Agreement for Tivozanib in Europe Dec 21 2015
    AVEO Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 17 2015
    AVEO PHARMACEUTICALS INC Financials Dec 08 2015
    Here is What Hedge Funds Think About NanoViricides Inc (NNVC) Nov 27 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK